Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes (T2DM) with HbA1c ≥8%

被引：0
作者：
Merker, Ludwig
Lund, Soren S.
Hantel, Stefan
Salsali, Afshin
Kim, Gabriel
Broedl, Uli C.
Woerle, Hans J.
Hach, Thomas
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1079-P
引用
收藏
页码：A280 / A281
页数：2
相关论文
共 50 条
[41]   GLYCATED HEMOGLOBIN (HBA1C) CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) TREATED WITH CANAGLIFLOZIN IN A REAL-WORLD SETTING [J].
Lefebvre, P. ;
Pilon, D. ;
Robitaille, M. ;
Lafeuille, M. ;
Chow, W. ;
Pfeifer, M. ;
Duh, M. S. .
VALUE IN HEALTH, 2015, 18 (03) :A57-A57
[42]   Vildagliptin is as effective as rosiglitazone in lowering HbA1c but without weight gain in drug-naive patients with type 2 diabetes (T2DM) [J].
Rosenstock, Julio ;
Baron, Michelle A. ;
Schweizer, Anja ;
Mills, David ;
Dejager, Sylvie .
DIABETES, 2006, 55 :A133-A133
[43]   Prevalence of Hemoglobin variants in T2DM through HbA1c assessment [J].
Gupta, S. ;
Baig, A. ;
Gupta, S. ;
Gupta, S. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
[44]   Perception, HbA1c and the Quality of Life of Diabetes Mellitus (T2DM) Patients at RSUD Abdul Azis Singkawang [J].
Faridah, Imaniar Noor ;
Masyithah, Nurul ;
Perwitasari, Dyah Aryani .
ADVANCED SCIENCE LETTERS, 2017, 23 (12) :12464-12468
[45]   Long-Term Clinical Outcomes Associated With LDL-C and HbA1c Goal Achievement in Patients With Type 2 Diabetes Mellitus (T2DM) [J].
Shi, Lizheng ;
Ye, Xin ;
Lu, Mei ;
Wu, Eric Q. ;
Sharma, Hari ;
Thomason, Darren ;
Fonseca, Vivian .
DIABETES, 2013, 62 :A392-A392
[46]   Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes [J].
Adham Mottalib ;
Veronica Salsberg ;
Barakatun-Nisak Mohd-Yusof ;
Wael Mohamed ;
Padraig Carolan ;
David M. Pober ;
Joanna Mitri ;
Osama Hamdy .
Nutrition Journal, 17
[47]   A Meta-Analysis to Quantify the Effect of Weight Reduction on HbA1c in Overweight or Obese Type 2 Diabetes Patients [J].
Gummesson, Anders ;
Nyman, Elisabeth ;
Knutsson, Mikael ;
Karpefors, Martin .
DIABETES, 2013, 62 :A539-A539
[48]   Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes [J].
Mottalib, Adham ;
Salsberg, Veronica ;
Mohd-Yusof, Barakatun-Nisak ;
Mohamed, Wael ;
Carolan, Padraig ;
Pober, David M. ;
Mitri, Joanna ;
Hamdy, Osama .
NUTRITION JOURNAL, 2018, 17
[49]   HBA1C REDUCTION WITH DIGITAL HEALTH DEVICES IN TYPE 2 DIABETES (T2DM): A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS [J].
Lee, F. ;
Han-Burgess, E. ;
Kennedy, A. ;
Serafini, P. ;
Pourrahmat, M. M. ;
Breznen, B. .
VALUE IN HEALTH, 2023, 26 (06) :S297-S297
[50]   FPG、GA、HbA1c及GA/HbA1c比值在T1DM/T2DM中的诊疗价值 [J].
王菊英 ;
姚琳芳 ;
周立荣 ;
李锋 .
中国免疫学杂志, 2015, 31 (11) :1536-1540
12345